Teona Avaliani

Tbilisi, TB, Georgia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Weight gain during tuberculosis treatment increases the risk of post-tuberculosis metabolic syndrome.

Weight gain during tuberculosis treatment increases the risk of post-tuberculosis metabolic syndrome.

Journal: medRxiv : the preprint server for health sciences
Published: December 08, 2025

Within-host evolution of drug tolerance in Mycobacterium tuberculosis.

Within-host evolution of drug tolerance in Mycobacterium tuberculosis.

Journal: JAC-antimicrobial resistance
Published: August 18, 2025

Clinical and bacterial determinants of unfavorable tuberculosis treatment outcomes: an observational study in Georgia.

Clinical and bacterial determinants of unfavorable tuberculosis treatment outcomes: an observational study in Georgia.

Journal: Genome medicine
Published: March 07, 2025

Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs.

Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs.

Journal: The New England journal of medicine
Published: January 03, 2025

USAGE OF SILVER NANOPARTICLES TO RESTORE MOXIFLOXACIN EFFICACY FOR FLUOROQUINOLONE-RESISTANT M. TUBERCULOSIS CULTURES.

USAGE OF SILVER NANOPARTICLES TO RESTORE MOXIFLOXACIN EFFICACY FOR FLUOROQUINOLONE-RESISTANT M. TUBERCULOSIS CULTURES.

Journal: Georgian medical news
Published: November 24, 2024

Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.

Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.

Journal: BMJ global health
Published: November 01, 2024

Cavitary lung lesions and quality of life after TB.

Cavitary lung lesions and quality of life after TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: September 28, 2024

EFFICACY AND SAFETY OF SILVER NANOCOMPOSITES ON RIFAMPICIN-RESISTANT M. TUBERCULOSIS STRAINS.

EFFICACY AND SAFETY OF SILVER NANOCOMPOSITES ON RIFAMPICIN-RESISTANT M. TUBERCULOSIS STRAINS.

Journal: Georgian medical news
Published: September 04, 2024

Drug-induced differential culturability in diverse strains of Mycobacterium tuberculosis.

Drug-induced differential culturability in diverse strains of Mycobacterium tuberculosis.

Journal: Scientific reports
Published: August 29, 2024

High rates of post-tuberculosis lung disease among persons successfully treated for drug-susceptible and resistant tuberculosis.

High rates of post-tuberculosis lung disease among persons successfully treated for drug-susceptible and resistant tuberculosis.

Journal: Thorax
Published: August 16, 2024

Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.

Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.

Journal: PloS one
Published: August 07, 2024

Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.

Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.

Journal: medRxiv : the preprint server for health sciences
Published: January 03, 2024
Showing 1-12 of 22

Last Updated: 09/26/2026